Search results

Australian Nuclear Science and Technology Organisation (ANSTO) is committed to protecting your personal information in accordance with the Privacy Act 1988 (Cth) (Privacy Act) and the Australian Privacy Principles.

Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.

Combining scientific expertise with more than $1.3 billion in unique operational assets to provide optimal radioactive waste solutions.

Do you love science? Here is a competition for you that combines chemistry and creativity! Discover the world of elements and create a poster for your favourite element!

ANSTO is seeking nominations for the ANSTO Australian Synchrotron Stephen Wilkins Thesis Medal.

ANSTO is seeking nominations for the ANSTO Australian Synchrotron Stephen Wilkins Thesis Medal.

ANSTO is seeking nominations for the ANSTO Australian Synchrotron Stephen Wilkins Thesis Medal.

ANSTO User Meeting 2021 - Speakers

Australia launched a new international development project in partnership with the International Atomic Energy Agency (IAEA) to advance ‘Rays of Hope’ in the Asia and Pacific region. 

ANSTO, Australia’s knowledge centre for nuclear science and technology, connects STEM graduates with industry to work on real-world challenges through its FutureNow Scholarships for 2022.

Strategic partnership with the University of Sydney expanded to continue a long history of research collaboration.

ANSTO is a partner on the National Space Qualification Network (NSQN) led by the Australian National University (ANU) that will transform Australia into a world-leading space centre by enhancing facilities to test payloads, components, and hardware prior to their use in harsh environments of space.

ANSTO is home to over AUD$1.3B state of the art instruments and science technology. To access ANSTO’s world-leading and highly specialised facilities and capabilities, please contact our Industry Engagement team. This way we can co-ordinate your enquiry and provide advice on your application.

Contributing to research that strengthens the defence of Australia

ANSTO’s National Deuteration Facility has provided deuterated cholesterol for international research to gain a better understanding of how the Spike protein of the COVID virus, SARS-Co-V-2, infects human cells through a membrane fusion mechanism.

In January 2026, Mr Michael Quigley AM, ANSTO Board Chair, shared ANSTO's Statement of Intent with the Minister for Industry and Innovation, and Minister for Science.